A novel treatment using supercharged immune cells appears to work against tumors in children with a rare kind of cancer, researchers reported Wednesday. The treatment — called CAR-T cell therapy — is already used to help the immune system fight leukemia and other cancers in the blood. They concluded that CAR-T therapy was “feasible and safe in treating high-risk neuroblastoma